3
into 1,2-anti-dialkoxychromane 13 in good yields through
2. (a) Gerlach, U.; Brendel, J.; Lang, H.-J.; Paulus, E. F.;
7
asymmetric epoxidation, HClO
4
-mediated hydrolysis, and O-
Weidmann, K.; Brüggemann, A.; Busch, A. E.; Suessbrich, H.;
Bleich, M.; Greger, R. J. Med. Chem. 2001, 44, 3831–3837. (b)
Sebille, S.; Gall, D.; de Tullio, P.; Florence, X.; Lebrun, P.;
Pirotte, B. J. Med. Chem. 2006, 49, 4690–4697. (c) Kim, Y.;
Griffin, J. M.; Nor, M. N. M.; Zhang, J.; Freestone, P. S.; Danesh-
Meyer, H. V.; Rupenthal, I. D.; Acosta, M.; Nicholson, L. F. B.;
O’Carroll, S. J.; Green, C. R. Neurotherapeutics 2017, 14, 1148–
1165. (d) Nagasawa, H.; Fujiki, A.; Fujikura, N.; Matsuda, T.;
Yamashita, T.; Inoue, H. Circ. J. 2002, 66, 185–191.
methylation. The reaction of 13 with CSI under the optimized
reaction conditions afforded 1,2-anti-amino alcohol adduct 14 in
8
8% yield with a diastereoselectivity of 96:4. Exchange of amido
group was performed with a treatment of TBAF and subsequent
-chlorobutanoyl chloride to furnish 16, which underwent
4
intramolecular cyclization to give 17 in 89% yield. Finally,
cromakalim was formed in 91% by demethylation reaction using
BBr .
3
3
.
(a) Lee, S. H.; Kim, I. S.; Li, Q. R.; Dong, G. R.; Jung, Y. H.
Tetrahedron Lett. 2011, 52, 1901–1904. (b) Kim, S. J.; Jeon, T.
H.; Min, I. S.; Kim, I. S.; Jung, Y. H. Tetrahedron Lett. 2012, 53,
3
. Conclusion
In conclusion, we have described the diastereoselective
amination of 1,2-anti-dialkoxychromane on chromane framework
3
680–3682.
using chlorosulfonyl isocyanate. Notably, the reaction of 1,2-
Total Synthesis of Chromanol 293B and
Cromakalim via Stereoselective Amination
of Chiral Benzylic Ethers
Leave this area blank for abstract info.
Sang-Ho Ma, Yeon Su Kim, Jun Min Jung, Pulla Reddy Boggu, Seung Chan Kim, In Su Kim and Young Hoon
Jung*
O
Me
S
O
Me
NHCO Me
N
2
OMe
O
NC
NC
OMe
NC
OH
NC
OMe
Me
CSI
4 steps
Me
Me
Me
Me
O
O
Me
9
0%, dr = 98:2 dr
Chromanol 293B
NHCO Me
2
O
N
OMe
O
OMe
NC
OMe
Me
CSI
NC
OH
4
steps
Me
Me
O
Me
Me
Cromakalim
O
Me
8
8%, dr = 96:4 dr
anti-dialkoxychromane with chlorosulfonyl isocyanate in toluene
solvent afforded exclusively the anti-1,2-amino alcohols in high
yield with excellent level of diastereoselectivities. These
4. (a) Lee, S. H.; Kim, I. S.; Li, Q. R.; Dong, G. R.; Jeong, L. S.;
Jung, Y. H. J. Org. Chem. 2011, 76, 10011–10019. (b) Lee, S. H.;
Park, S. J.; Kim, I. S.; Jung, Y. H. Tetrahedron 2013, 69, 1877–
1880. (c) Jung, Y. H.; Kim, S. I.; Hong, Y. J.; Park, S. J.; Kang, K.
T.; Kim, S. Y.; Kim, I. S. Tetrahedron 2015, 71, 1068–1073.
N
observations can be explained by S i mechanism leading to
retention of stereochemistry of methyl ethers at the benzylic
position. Therefore, we believe that this synthetic strategy can be
readily applied to the preparation of heterocyclic molecules with
amine functionality at the benzylic position.
5
.
(a) Wang, D.; Wang, W.; Wang, X.; Chen, Y.; Gao, A.; Sun, L. J.
Catal. 2006, 237, 248–254. (b) Wang, Q.; She, X.; Ren, X.; Ma,
J.; Pan, X. Tetrahedron: Asymmetry 2004, 15, 29–34.
Acknowledgements
6
7
.
.
Jacquemard, U.; Bénéteau, V.; Lefoix, M.; Routier, S.; Mérour, J.-
This work was supported by the National Research Foundation
of Korea (NRF) funded by the Korea government (MSIP) (No.
Y.; Coudert, G. Tetrahedron 2004, 60, 10039–10047.
Patel, R. N.; Banerjee, A.; Davis, B.; Howell, J.; MaNamee, C.;
Brzozowaski, D.; North, J.; Kronenthal, D.; Szarka, L. Bioorg.
Med. Chem. 1994, 2, 535–542.
2
016R1D1A1B03932216).
Appendix A. Supplementary data
Supplementary data (experimental and spectroscopic data for
all compounds) associated with this article can be found in the
online version, at http://
Graphical Abstract
To create your abstract, type over the instructions in the
template box below.
Fonts or abstract dimensions should not be changed or altered.
Appendix A. Supplementary data
Supplementary data (experimental and spectroscopic data for all
compounds) associated with this article can be found in the
online version, at http://
References and notes
1
.
(a) Radesca, L.; Bowen, W. D.; Paolo, L. D.; De Costa, B. R. J.
Med. Chem. 1991, 34, 3058–3065. (b) Roxburgh, C. J. Synthesis
1
996, 307–320. (c) Horarth, J.; Lloyd, D. G. J. Antimicrob.
Chemother. 2000, 46, 625–628.